Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC). Final results of a Phase II study
- 1 March 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (11) , S68
- https://doi.org/10.1016/s0959-8049(02)80203-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: